Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Birmingham Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of St Andrews Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Manchester Featured PhD Programmes
"motor" AND "neuron" AND …×
10 miles

motor neuron disease PhD Projects, Programs & Scholarships

We have 13 motor neuron disease PhD Projects, Programs & Scholarships

  • "motor" AND "neuron" AND "disease" ×
  • clear all
Order by 
Showing 1 to 10 of 13
  MRC Precision Medicine DTP: Investigating modifier transcripts in mouse models of motor neuron disease
  Dr L Murray, Dr E Hudlund
Application Deadline: 7 January 2019
The term “motor neuron disease” encompasses a spectrum of disorders in which motor neurons are the primary pathological target.
  Investigating modifiers transcripts in models of motor neuron disease
  Dr L Murray, Prof T Gillingwater
Application Deadline: 7 January 2019
The term ‘motor neuron disease’ refers to a group of disorders in which motor neurons are the primary target. The search for therapeutic agents to treat motor neuron disease often focuses on one subtype with a specific cause.
  Investigating the pathophysiology of Motor Neuron Disease (MND/ALS) using rodent and human iPSC-based models
  Prof G Miles, Prof S Chandran
Application Deadline: 7 January 2019
There is growing evidence that early changes in neuronal function contribute to the pathogenesis of Motor Neuron Disease/Amyotrophic Lateral Sclerosis (MND/ALS).
  Developing the next generation of therapies for the childhood motor neuron disease, spinal muscular atrophy (SMA)
  Research Group: The Euan MacDonald Centre for Motor Neurone disease
  Prof T Gillingwater, Prof S Parson
Application Deadline: 7 January 2019
Spinal muscular atrophy (SMA) is a motor neuron disease caused by mutations in the SMN1 gene. Excitingly, SMA has recently moved into a therapeutic era, with an approved SMN genetargeted therapy (nusinersen/Spinraza™) that improves many aspects of disease, including motor function and survival.
  Developing the next generation of therapies for the childhood motor neuron disease, spinal muscular atrophy (SMA)
  Prof T Gillingwater, Prof S Parson
Application Deadline: 7 January 2019
Spinal muscular atrophy (SMA) is a motor neuron disease caused by mutations in the SMN1 gene. Excitingly, SMA has recently moved into a therapeutic era, with an approved SMN gene-targeted therapy (nusinersen/Spinraza™) that improves many aspects of disease, including motor function and survival.
  Excitatory interneuron defects in motor neurone disease
  Dr J McDearmid, Dr W NORTON
Applications accepted all year round
Amyotrophic lateral sclerosis (ALS) is an untreatable disease that causes degeneration of motor neurons, typically resulting in death within 2-3 years of diagnosis.
  MRC-funded PhD in Precision Medicine 2018/2019
 . We are offering up to 32 PhD studentships in 2019/20 to high quality UK/EU applicants, providing full tuition fees and a stipend of at least £14,777 per year.
  Characterising the human Amyotrophic Lateral Sclerosis (ALS) synaptic proteome
  Dr C Henstridge, Dr T Wishart
Application Deadline: 1 February 2019
Amyotrophic Lateral Sclerosis (ALS) is caused by the breakdown of upper and lower motor neurons leading to the progressive weakness and atrophy of muscle, often resulting in respiratory failure and death within a few years of diagnosis.
  MRC DiMeN Doctoral Training Partnership: From single-molecule to synchrotron: New tools for investigating the molecular mechanisms of Aicardi-Goutières Syndrome and other aberrant DNA diseases
  Dr T Craggs, Prof S El-Khamisy, Dr R Rambo
Application Deadline: 21 January 2019
This studentship is focused on developing new biophysical tools to understand the molecular basis of aberrant DNA diseases.
  Propensity Score estimation and matching for multiple treatment comparisons in observational studies
  Prof S Walters, Dr R Jacques
Application Deadline: 23 January 2019
Gastrostomy feeding is commonly used to support patients with amyotrophic lateral sclerosis who develop severe dysphagia.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.